DK0594570T3 - Colestyraminholdige mikrotabletter som lipidsænkende middel - Google Patents

Colestyraminholdige mikrotabletter som lipidsænkende middel

Info

Publication number
DK0594570T3
DK0594570T3 DK90913811.7T DK90913811T DK0594570T3 DK 0594570 T3 DK0594570 T3 DK 0594570T3 DK 90913811 T DK90913811 T DK 90913811T DK 0594570 T3 DK0594570 T3 DK 0594570T3
Authority
DK
Denmark
Prior art keywords
colestyramine
lipid
lowering agent
containing micro
micro tablets
Prior art date
Application number
DK90913811.7T
Other languages
English (en)
Inventor
Thomas Moest
Erwin Spiegel
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3930168A external-priority patent/DE3930168A1/de
Priority claimed from DE19893930206 external-priority patent/DE3930206A1/de
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of DK0594570T3 publication Critical patent/DK0594570T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90913811.7T 1989-09-09 1990-09-07 Colestyraminholdige mikrotabletter som lipidsænkende middel DK0594570T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3930168A DE3930168A1 (de) 1989-09-09 1989-09-09 Verbesserte verabreichungsform fuer colestyramin
DE19893930206 DE3930206A1 (de) 1989-09-09 1989-09-09 Pharmazeutische erzeugnisse

Publications (1)

Publication Number Publication Date
DK0594570T3 true DK0594570T3 (da) 1995-09-11

Family

ID=25884990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90913811.7T DK0594570T3 (da) 1989-09-09 1990-09-07 Colestyraminholdige mikrotabletter som lipidsænkende middel

Country Status (10)

Country Link
EP (1) EP0594570B1 (da)
JP (1) JPH05500213A (da)
KR (1) KR920703071A (da)
AT (1) ATE125448T1 (da)
AU (1) AU638493B2 (da)
CA (1) CA2065151A1 (da)
DE (1) DE59009451D1 (da)
DK (1) DK0594570T3 (da)
IL (1) IL95574A (da)
WO (1) WO1991003249A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3777864A1 (en) 2010-11-08 2021-02-17 Albireo AB Ibat inhibitors for the treatment of liver diseases
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
JP6830969B2 (ja) * 2016-02-09 2021-02-17 アルビレオ・アクチボラグ コレスチラミンペレット剤及びその調製のための方法
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
CN108601744B (zh) * 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
EP3413878B1 (en) * 2016-02-09 2021-04-14 Albireo AB Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
WO2019032027A1 (en) * 2017-08-09 2019-02-14 Albireo Ab CHOLESTYRAMINE TABLETS, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE
JP2020530448A (ja) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CN112449637B (zh) 2018-06-05 2024-03-19 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
EP3810581A1 (en) 2018-06-20 2021-04-28 Albireo AB Crystal modifications of odevixibat
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
JP2023504643A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CA3158276A1 (en) 2019-12-04 2021-06-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
PE20230234A1 (es) 2019-12-04 2023-02-07 Albireo Ab Compuestos de benzoti(di)azepina y su uso como moduladores del acido biliar
JP2023504644A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2023537285A (ja) 2020-08-03 2023-08-31 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
CA3196488A1 (en) 2020-11-12 2022-05-19 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
KR20230117393A (ko) 2020-12-04 2023-08-08 알비레오 에이비 벤조티아(디)아제핀 화합물 및 담즙산 조절제로서의용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
GB1566609A (en) 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
EP0166315B1 (de) 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4814354A (en) 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
ZA876640B (en) 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
EP0323666B1 (en) * 1987-12-29 1992-03-25 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
DE3808191C2 (de) 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
US4931280A (en) 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine

Also Published As

Publication number Publication date
WO1991003249A1 (de) 1991-03-21
CA2065151A1 (en) 1991-03-10
IL95574A (en) 1994-11-11
DE59009451D1 (de) 1995-08-31
EP0594570A1 (de) 1994-05-04
EP0594570B1 (de) 1995-07-26
JPH05500213A (ja) 1993-01-21
KR920703071A (ko) 1992-12-17
IL95574A0 (en) 1991-06-30
AU6405790A (en) 1991-04-08
AU638493B2 (en) 1993-07-01
ATE125448T1 (de) 1995-08-15

Similar Documents

Publication Publication Date Title
DK0594570T3 (da) Colestyraminholdige mikrotabletter som lipidsænkende middel
FI924553A (fi) Tiofensulfonamider anvaendbara som kolanhydrasinhibitorer
NO900227D0 (no) Ekstruderbar elastisk gel for anvendelse som baerer for terapeutisk middel.
FI921606A (fi) Mikroperoxidas innehaollande hemopeptid som aktiv komponent.
NL960002I1 (nl) Nieuwe taxolderivaten,werkwijzen ter bereiding daarvan en farmaceutische preparaten,die deze bevatten.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FI922454A (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI921279A0 (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
FI905933A (fi) Multilager film som haeftar vid koett.
FI900762A0 (fi) Tris-hydroximetylalkanestrar som fettimitationer med laog kalorihalt.
FI900763A0 (fi) Tris-hydroximetyl-laegre alkanestrar som fettsurrogat.
FI892214A (fi) Kopparlegering foer anvaendning som motstaondssvetselektrod.
FI895483A (fi) Som slaglod anvaendbara kopparblandningar.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
DK0577745T3 (da) Bis-naphtalimider indeholdende amid- og thioamid-forbindelsesstykker som anticancermidler.
NO901672L (no) Blanding til bruk som overflateaktivt middel i vaskemidler
FI945609A0 (fi) Makromonomeereja sisältävät vesipitoiset lateksit
FI900940A0 (fi) Tryckt kretsskiva som foerhindrar elektromagnetisk interferens.
FI905238A0 (fi) Foerbraenningsmotor foer fartyg som transporterar foerbraenningsgas.
NO901169D0 (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.
FI883453A (fi) Bicyklooktanderivat anvaendbara som pesticider och foerfarande foer deras framstaellning.
ATE80143T1 (de) Isomere formyl-trimethylbicyclo(2,2,2)oct-7-ene.
FI903111A0 (fi) Bis (benzylpyrrolidin) derivat som dopaminantagonister.
DE69017188D1 (de) Projektionsanzeigevorrichtung.
NO901200D0 (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.